Patents by Inventor Scott C. Mauldin

Scott C. Mauldin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-viral compounds
    Patent number: 6180816
    Abstract: The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.
    Type: Grant
    Filed: April 10, 2000
    Date of Patent: January 30, 2001
    Assignee: Eli Lilly and Company
    Inventors: Scott C. Mauldin, John E. Munroe
  • Anti-viral compounds
    Patent number: 6180815
    Abstract: The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.
    Type: Grant
    Filed: April 10, 2000
    Date of Patent: January 30, 2001
    Assignee: Eli Lilly and Company
    Inventors: Scott C. Mauldin, John E. Munroe
  • Anti-viral compounds
    Patent number: 6175034
    Abstract: The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.
    Type: Grant
    Filed: April 10, 2000
    Date of Patent: January 16, 2001
    Assignee: Eli Lilly and Company
    Inventors: Scott C. Mauldin, John E. Munroe
  • Anti-viral compounds
    Patent number: 6156924
    Abstract: The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.
    Type: Grant
    Filed: January 6, 1999
    Date of Patent: December 5, 2000
    Assignee: Eli Lilly and Company
    Inventors: William J. Hornback, Scott C. Mauldin, John E. Munroe
  • Anti-viral method
    Patent number: 6127422
    Abstract: A method of inhibiting an envelope virus selected from the group consisting of influenza bovine diarrheal, hepatitis C and tick borne encephalitis virus that udergoes hemagglutinin-mediated fusion with a host cell is disclosed which comprises administering to a virus-infected cell, a cell susceptible of infection or a mammal in need thereof, an effective amount of a compound as defined by Formula I in the specification.
    Type: Grant
    Filed: January 6, 1999
    Date of Patent: October 3, 2000
    Assignee: Eli Lilly and Company
    Inventors: Joseph M. Colacino, William J. Hornback, Scott C. Mauldin, John E. Munroe, Joseph C. Tang
  • Anti-viral compounds
    Patent number: 6124494
    Abstract: The present invention provides compounds which inhibit. an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.
    Type: Grant
    Filed: January 6, 1999
    Date of Patent: September 26, 2000
    Assignee: Eli Lilly and Company
    Inventors: Scott C. Mauldin, John E. Munroe
  • Anti-viral compounds
    Patent number: 6103923
    Abstract: The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.
    Type: Grant
    Filed: January 6, 1999
    Date of Patent: August 15, 2000
    Assignee: Eli Lilly and Company
    Inventors: Scott C. Mauldin, John E. Munroe
  • Anti-viral compounds
    Patent number: 6100426
    Abstract: The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.
    Type: Grant
    Filed: January 6, 1999
    Date of Patent: August 8, 2000
    Assignee: Eli Lilly and Company
    Inventors: Scott C. Mauldin, John E. Munroe
  • Anti-viral compounds
    Patent number: 6096917
    Abstract: The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.
    Type: Grant
    Filed: January 6, 1999
    Date of Patent: August 1, 2000
    Assignee: Eli Lilly and Company
    Inventors: William J. Hornback, Scott C. Mauldin, John E. Munroe